Motivation, reward, and Parkinson's disease: influence of dopatherapy
Identifieur interne : 003495 ( Main/Exploration ); précédent : 003494; suivant : 003496Motivation, reward, and Parkinson's disease: influence of dopatherapy
Auteurs : V. Czernecki [France] ; B. Pillon [France] ; J. L. Houeto [France] ; J. B. Pochon [France] ; R. Levy [France] ; B. Dubois [France]Source :
- Neuropsychologia [ 0028-3932 ] ; 2002.
Descripteurs français
- Pascal (Inist)
- Wicri :
- topic : Homme.
English descriptors
- KwdEn :
- Adult, Antiparkinson Agents (therapeutic use), Chemotherapy, Cognition Disorders (diagnosis), Corpus Striatum (physiopathology), Depressive Disorder, Major (etiology), Dopamine, Extinction, Psychological, Female, Frontal Lobe (physiopathology), Human, Humans, Levodopa, Levodopa (therapeutic use), Male, Motivation, Nerve Net (physiopathology), Neuropsychological Tests, Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson Disease (psychology), Parkinson disease, Reinforcement, Reinforcement (Psychology), Reward, Treatment.
- MESH :
- chemical , therapeutic use : Antiparkinson Agents, Levodopa.
- diagnosis : Cognition Disorders.
- drug therapy : Parkinson Disease.
- etiology : Depressive Disorder, Major.
- physiopathology : Corpus Striatum, Frontal Lobe, Nerve Net, Parkinson Disease.
- psychology : Parkinson Disease.
- Adult, Extinction, Psychological, Female, Humans, Male, Motivation, Neuropsychological Tests, Reinforcement (Psychology), Reward.
Abstract
"Orbitofrontal" and "cingulate" striatofrontal loops and the mesolimbic dopaminergic system that modulates their function have been implicated in motivation and sensitivity to reinforcement in animals. Parkinson's disease (PD) provides a model to assess their implications in humans. The aims of the study were to investigate motivation and sensitivity to reinforcement in non-demented and -depressed PD patients and to evaluate the influence of dopaminergic therapy by comparing patients in "on" (with L-Dopa) and "off" (without L-Dopa) states. Twenty-three PD patients were compared, in both the "on" and "off" states, to 28 controls, using: (1) an Apathy Scale; (2) Stimulus-Reward Learning, Reversal, and Extinction tasks; and (3) a Gambling task. PD patients were found: (1) mildly apathetic; (2) impaired on Stimulus-Reward Learning and Reversal, but not on Extinction; and (3) able to progress in the Gambling task during the first, but not the second assessment. There was no significant correlation between these various deficits. L-Dopa treatment clearly improved motivation, but had more limited and contrasting effects on other variables, decreasing the number of omission errors in Reversal, but increasing the number of perseveration errors in Extinction. These results suggest: (1) an implication of striatofrontal loops in human motivation and explicit and implicit sensitivity to reinforcement; (2) a positive influence of L-Dopa treatment on the subjective evaluation of motivation, but contrasting effects on reward sensitivity.
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: 001034
- to stream PascalFrancis, to step Curation: 000400
- to stream PascalFrancis, to step Checkpoint: 000F16
- to stream Main, to step Merge: 003A31
- to stream PubMed, to step Corpus: 001218
- to stream PubMed, to step Curation: 001177
- to stream PubMed, to step Checkpoint: 001177
- to stream Ncbi, to step Merge: 000286
- to stream Ncbi, to step Curation: 000286
- to stream Ncbi, to step Checkpoint: 000286
- to stream Main, to step Merge: 003825
- to stream Main, to step Curation: 003495
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Motivation, reward, and Parkinson's disease: influence of dopatherapy</title><author><name sortKey="Czernecki, V" sort="Czernecki, V" uniqKey="Czernecki V" first="V." last="Czernecki">V. Czernecki</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Houeto, J L" sort="Houeto, J L" uniqKey="Houeto J" first="J. L." last="Houeto">J. L. Houeto</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Pochon, J B" sort="Pochon, J B" uniqKey="Pochon J" first="J. B." last="Pochon">J. B. Pochon</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Levy, R" sort="Levy, R" uniqKey="Levy R" first="R." last="Levy">R. Levy</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">INIST</idno><idno type="inist">03-0004494</idno><date when="2002">2002</date><idno type="stanalyst">PASCAL 03-0004494 INIST</idno><idno type="RBID">Pascal:03-0004494</idno><idno type="wicri:Area/PascalFrancis/Corpus">001034</idno><idno type="wicri:Area/PascalFrancis/Curation">000400</idno><idno type="wicri:Area/PascalFrancis/Checkpoint">000F16</idno><idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000F16</idno><idno type="wicri:doubleKey">0028-3932:2002:Czernecki V:motivation:reward:and</idno><idno type="wicri:Area/Main/Merge">003A31</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:12417456</idno><idno type="wicri:Area/PubMed/Corpus">001218</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001218</idno><idno type="wicri:Area/PubMed/Curation">001177</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001177</idno><idno type="wicri:Area/PubMed/Checkpoint">001177</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001177</idno><idno type="wicri:Area/Ncbi/Merge">000286</idno><idno type="wicri:Area/Ncbi/Curation">000286</idno><idno type="wicri:Area/Ncbi/Checkpoint">000286</idno><idno type="wicri:doubleKey">0028-3932:2002:Czernecki V:motivation:reward:and</idno><idno type="wicri:Area/Main/Merge">003825</idno><idno type="wicri:Area/Main/Curation">003495</idno><idno type="wicri:Area/Main/Exploration">003495</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Motivation, reward, and Parkinson's disease: influence of dopatherapy</title><author><name sortKey="Czernecki, V" sort="Czernecki, V" uniqKey="Czernecki V" first="V." last="Czernecki">V. Czernecki</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Houeto, J L" sort="Houeto, J L" uniqKey="Houeto J" first="J. L." last="Houeto">J. L. Houeto</name><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Pochon, J B" sort="Pochon, J B" uniqKey="Pochon J" first="J. B." last="Pochon">J. B. Pochon</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Levy, R" sort="Levy, R" uniqKey="Levy R" first="R." last="Levy">R. Levy</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name><affiliation wicri:level="3"><inist:fA14 i1="01"><s1>INSERM E 007, Hôpital de la Salpêytière</s1><s2>Paris</s2><s3>FRA</s3><sZ>1 aut.</sZ><sZ>2 aut.</sZ><sZ>4 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation><affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Fédération de Neurologie, Hôpital de la Salpêtrière, 47 Blvd de l'Hôpital</s1><s2>75651 Paris</s2><s3>FRA</s3><sZ>2 aut.</sZ><sZ>3 aut.</sZ><sZ>5 aut.</sZ><sZ>6 aut.</sZ></inist:fA14><country>France</country><placeName><region type="region" nuts="2">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author></analytic><series><title level="j" type="main">Neuropsychologia</title><title level="j" type="abbreviated">Neuropsychologia</title><idno type="ISSN">0028-3932</idno><imprint><date when="2002">2002</date></imprint></series></biblStruct></sourceDesc><seriesStmt><title level="j" type="main">Neuropsychologia</title><title level="j" type="abbreviated">Neuropsychologia</title><idno type="ISSN">0028-3932</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Antiparkinson Agents (therapeutic use)</term><term>Chemotherapy</term><term>Cognition Disorders (diagnosis)</term><term>Corpus Striatum (physiopathology)</term><term>Depressive Disorder, Major (etiology)</term><term>Dopamine</term><term>Extinction, Psychological</term><term>Female</term><term>Frontal Lobe (physiopathology)</term><term>Human</term><term>Humans</term><term>Levodopa</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Motivation</term><term>Nerve Net (physiopathology)</term><term>Neuropsychological Tests</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson Disease (psychology)</term><term>Parkinson disease</term><term>Reinforcement</term><term>Reinforcement (Psychology)</term><term>Reward</term><term>Treatment</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antiparkinson Agents</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Cognition Disorders</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Depressive Disorder, Major</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Corpus Striatum</term><term>Frontal Lobe</term><term>Nerve Net</term><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="psychology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Extinction, Psychological</term><term>Female</term><term>Humans</term><term>Male</term><term>Motivation</term><term>Neuropsychological Tests</term><term>Reinforcement (Psychology)</term><term>Reward</term></keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term><term>Motivation</term><term>Récompense</term><term>Renforcement</term><term>Chimiothérapie</term><term>Lévodopa</term><term>Dopamine</term><term>Traitement</term><term>Homme</term></keywords><keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">"Orbitofrontal" and "cingulate" striatofrontal loops and the mesolimbic dopaminergic system that modulates their function have been implicated in motivation and sensitivity to reinforcement in animals. Parkinson's disease (PD) provides a model to assess their implications in humans. The aims of the study were to investigate motivation and sensitivity to reinforcement in non-demented and -depressed PD patients and to evaluate the influence of dopaminergic therapy by comparing patients in "on" (with L-Dopa) and "off" (without L-Dopa) states. Twenty-three PD patients were compared, in both the "on" and "off" states, to 28 controls, using: (1) an Apathy Scale; (2) Stimulus-Reward Learning, Reversal, and Extinction tasks; and (3) a Gambling task. PD patients were found: (1) mildly apathetic; (2) impaired on Stimulus-Reward Learning and Reversal, but not on Extinction; and (3) able to progress in the Gambling task during the first, but not the second assessment. There was no significant correlation between these various deficits. L-Dopa treatment clearly improved motivation, but had more limited and contrasting effects on other variables, decreasing the number of omission errors in Reversal, but increasing the number of perseveration errors in Extinction. These results suggest: (1) an implication of striatofrontal loops in human motivation and explicit and implicit sensitivity to reinforcement; (2) a positive influence of L-Dopa treatment on the subjective evaluation of motivation, but contrasting effects on reward sensitivity.</div></front></TEI><affiliations><list><country><li>France</li></country><region><li>Île-de-France</li></region><settlement><li>Paris</li></settlement></list><tree><country name="France"><region name="Île-de-France"><name sortKey="Czernecki, V" sort="Czernecki, V" uniqKey="Czernecki V" first="V." last="Czernecki">V. Czernecki</name></region><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name><name sortKey="Dubois, B" sort="Dubois, B" uniqKey="Dubois B" first="B." last="Dubois">B. Dubois</name><name sortKey="Houeto, J L" sort="Houeto, J L" uniqKey="Houeto J" first="J. L." last="Houeto">J. L. Houeto</name><name sortKey="Levy, R" sort="Levy, R" uniqKey="Levy R" first="R." last="Levy">R. Levy</name><name sortKey="Levy, R" sort="Levy, R" uniqKey="Levy R" first="R." last="Levy">R. Levy</name><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name><name sortKey="Pillon, B" sort="Pillon, B" uniqKey="Pillon B" first="B." last="Pillon">B. Pillon</name><name sortKey="Pochon, J B" sort="Pochon, J B" uniqKey="Pochon J" first="J. B." last="Pochon">J. B. Pochon</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003495 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003495 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= Pascal:03-0004494
|texte= Motivation, reward, and Parkinson's disease: influence of dopatherapy
}}
| This area was generated with Dilib version V0.6.29. |  |